Jeffrey S. Hackman - 18 Feb 2026 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Executive Officer, Director
Signature
/s/ Jeff Hackman
Issuer symbol
FENC
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 18:44:43 UTC
Previous filing
19 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hackman Jeffrey S. Chief Executive Officer, Director 68 TW ALEXANDER DRIVE, PO BOX 13628, RESEARCH TRIANGLE PARK /s/ Jeff Hackman 19 Feb 2026 0001926254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $0 +13,710 +91% $0.000000 28,710 18 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement of PSUs that vested on February 18, 2026.